Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication

Circulation Journal

Volumn 76, Issue 6, 2012, Pages 1486-1493

  Serizawa, Fukashi ^a   Ito, Kenta ^a   Kawamura, Keiichiro ^a   Tsuchida, Ken ^a   Hamada, Yo ^a   Zukeran, Tsutomu ^a   Shimizu, Takuya ^a   Akamatsu, Daijiro ^a   Hashimoto, Munetaka ^a   Goto, Hitoshi ^a   Watanabe, Tetsuo ^b   Sato, Akira ^a   Shimokawa, Hiroaki ^a   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY HOSPITAL   (Japan)

Author keywords

Angiogenesis; Ischemia; Peripheral artery disease; Shock wave therapy

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; INTERMITTENT CLAUDICATION; MALE; NEAR INFRARED SPECTROSCOPY; OXYGEN SUPPLY; PAIN ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUESTIONNAIRE; TISSUE OXYGENATION; TREADMILL EXERCISE; WALKING;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; EXERCISE TEST; FEMALE; HIGH-ENERGY SHOCK WAVES; HUMANS; INTERMITTENT CLAUDICATION; JAPAN; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PAIN; PAIN MEASUREMENT; PERIPHERAL ARTERIAL DISEASE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONIC THERAPY; WALKING;

EID: 84861635490     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1216     Document Type: Article

References (37)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5-S67.
2. Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds 2011; 10: 152-166.
3. Soga Y, Yokoi H, Urakawa T, Tosaka A, Iwabuchi M, Nobuyoshi M. Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease. Circ J 2010; 74: 1689-1695.
4. Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of Transatlantic Intersociety Consensus Class C and D aorto-iliac lesions. J Vasc Surg 2011; 53: 1728-1737.
5. Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, et al. Long-term results of the S.M.A.R.T. ControlTM stent for superficial femoral artery lesions, J-SMART registry. Circ J 2011; 75: 939-944.
6. Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg 2011; 53: 992-999.
7. Troisi N, Dorigo W, Pratesi G, Alessi Innocenti A, Pulli R, Pratesi C. Below-knee revascularization in patients with critical limb ischemia: Long-term comparison of redo vs primary interventions. J Cardiovasc Surg (Torino) 2008; 49: 489-495.
8. Gandini R, Volpi T, Pampana E, Uccioli L, Versaci F, Simonetti G. Applicability and clinical results of percutaneous transluminal angioplasty with a novel, long, conically shaped balloon dedicated for below-the knee interventions. J Cardiovasc Surg (Torino) 2009; 50: 365-371.
9. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004; 110: 3055-3061.
10. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006; 17: 63-70.
11. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 2008; 214: 151-158.
12. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. Tohoku J Exp Med 2009; 219: 1-9.
13. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, et al. Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 2010; 74: 589-591.
14. Ito K, Fukumoto Y, Shimokawa H. Extracorporeal shock wave therapy for ischemic cardiovascular disorders. Am J Cardiovasc Drugs 2011; 11: 295-302.
15. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007; 18: 397-404.
16. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, Takeda M, et al. Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis 2010; 21: 304-311.
17. Serizawa F, Ito K, Matsubara M, Sato A, Shimokawa H, Satomi S. Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema. Eur J Vasc Endovasc Surg 2011; 42: 254-260.
18. Ikeda S, Kobayashi M, Shigematsu H, Matsuo H, Ota T, Sugimoto I, et al. Development of the Japanese version of walking impairment questionnaire (WIQ). J Jpn Coll Angiol 2005; 45: 233-240.
19. Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: Meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002; 50: 1939-1946.
20. Norgren L, Jawien A, Matyas L, Riegerd H, Arita K. Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication: A phase II European study. Vasc Med 2006; 11: 75-83.
21. Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA, McDermott M. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med 2010; 15: 181-188.
22. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941-1951.
23. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008; 4: CD000990.
24. Tebbutt N, Robinson L, Todhunter J, Jonker L. A plantar flexion device exercise programme for patients with peripheral arterial disease: A randomised prospective feasibility study. Physiotherapy 2011; 97: 244-249.
25. Saggini R, Figus A, Troccola A, Cocco V, Saggini A, Scuderi N. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 2008; 34: 1261-1271.
26. Kuo YR, Wang CT, Wang FS, Chiang YC, Wang CJ. Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair Regen 2009; 17: 522-530.
27. Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, et al. The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord 2009; 10: 54.
28. Ottomann C, Hartmann B, Tyler J, Maier H, Thiele R, Schaden W, et al. Prospective randomized trial of accelerated re-epithelization of skin graft donor sites using extracorporeal shock wave therapy. J Am Coll Surg 2010; 211: 361-367.
29. Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, et al. Extracorporeal shock waves: From lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005; 12: 89-96.
30. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, Wang CJ. Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 2008; 72: 150-156.
31. Nurzynska D, Di Meglio F, Castaldo C, Arcucci A, Marlinghaus E, Russo S, et al. Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart. Ultrasound Med Biol 2008; 34: 334-342.
32. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114: 2823-2830.
33. Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral beraprost sodium, a prostaglandin I2 analogue, for intermittent claudication: A double-blind, randomized, multicenter controlled trial [Beraprost et Claudication Intermittente (BERCI) research group]. Circulation 2000; 102: 426-431.
34. Askew CD, Green S, Walker PJ, Kerr GK, Green AA, Williams AD, et al. Skeletal muscle phenotype is associated with exercise tolerance in patients with peripheral arterial disease. J Vasc Surg 2005; 41: 802-807.
35. Mitchell RG, Duscha BD, Robbins JL, Redfern SI, Chung J, Bensimhon DR, et al. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med 2007; 12: 285-290.
36. Bauer TA, Brass EP, Barstow TJ, Hiatt WR. Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol 2007; 100: 143-151.
37. Bauer TA, Brass EP, Hiatt WR. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 2004; 40: 488-493.